Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 5/2010

01-10-2010 | Research Article

Is deep vein thrombosis prophylaxis appropriate in the medical wards? A clinical pharmacists’ intervention study

Authors: Hossein Khalili, Simin Dashti-Khavidaki, Azita Hajhossein Talasaz, Laleh Mahmoudi, Kaveh Eslami, Hamed Tabeefar

Published in: International Journal of Clinical Pharmacy | Issue 5/2010

Login to get access

Abstract

Objective Venous thromboembolism is a major cause of mortality and morbidity in hospitalized patients. To evaluate physicians’ approach to patients’ thrombosis risk assessment and practice of thromboembolism prophylaxis in a teaching hospital, we designed an interventional prospective study. Setting This pre and post interventional study was conducted in the infectious diseases ward of Imam Khomeini referral hospital, Tehran, Iran. Method Patients’ risk factors for thromboembolism during hospitalization course and physicians’ thromboembolism prophylaxis approaches were evaluated in a pre and post clinical pharmacists’ interventional study. Main outcome measure An internal guideline for prescribing anticoagulants as deep vein thrombosis (DVT) prophylaxis was prepared by clinical pharmacists and the appropriateness of anticoagulants’ prescription was evaluated and compared before and after the implementation of consensual guideline. Results In the pre-intervention phase 69.9% of patients had appropriate indication and received thromboembolism prophylaxis and in 31.1% of enrolled patients anticoagulants were prescribed inappropriately. Prescription of anticoagulants was appropriate in 88.4% of patients during the post interventional phase of the study while 11.6% of admitted patients received prophylaxis improperly. A decrease in the number of patients who had the criterion for DVT prophylaxis but anticoagulants were not administered after the implementation of internal guideline was statistically significant (P = 0.001).Conclusion The implementation of clinical pharmacists’ prepared protocol helped to a great extent in the improvement of administrating DVT prophylaxis appropriately in patients.
Literature
1.
go back to reference Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW, American College of Chest Physicians. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest. 2008;133(6 Suppl):381S–453S.CrossRefPubMed Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW, American College of Chest Physicians. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest. 2008;133(6 Suppl):381S–453S.CrossRefPubMed
2.
go back to reference Fowkes FJ, Price JF, Fowkes FG. Incidence of diagnosed deep vein thrombosis in the general population: systematic review. Eur J Vasc Endovasc Surg. 2003;25:1–5.CrossRefPubMed Fowkes FJ, Price JF, Fowkes FG. Incidence of diagnosed deep vein thrombosis in the general population: systematic review. Eur J Vasc Endovasc Surg. 2003;25:1–5.CrossRefPubMed
3.
go back to reference White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107:14–8.CrossRef White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107:14–8.CrossRef
4.
go back to reference Gerotziafas GT, Samama MM. Prophylaxis of venous thromboembolism in medical patients. Curr Opin Pulm Med. 2004;10(5):356–65.CrossRefPubMed Gerotziafas GT, Samama MM. Prophylaxis of venous thromboembolism in medical patients. Curr Opin Pulm Med. 2004;10(5):356–65.CrossRefPubMed
5.
go back to reference Tapson VF, Hyers TM, et al. Antithrombotic therapy practices in US hospitals in an era of practice guidelines. Arch Intern Med. 2005;165:1458–64.CrossRefPubMed Tapson VF, Hyers TM, et al. Antithrombotic therapy practices in US hospitals in an era of practice guidelines. Arch Intern Med. 2005;165:1458–64.CrossRefPubMed
6.
go back to reference Baglin TP, White K, Charles A. Fatal pulmonary embolism in hospitalised medical patients. J Clin Pathol. 1997;50:609–10.CrossRefPubMed Baglin TP, White K, Charles A. Fatal pulmonary embolism in hospitalised medical patients. J Clin Pathol. 1997;50:609–10.CrossRefPubMed
7.
go back to reference Cohen AT, Edmondson RA, Phillips MJ, et al. The changing pattern of venous thromboembolic disease. Haemostasis. 1996;26:65–71.PubMed Cohen AT, Edmondson RA, Phillips MJ, et al. The changing pattern of venous thromboembolic disease. Haemostasis. 1996;26:65–71.PubMed
8.
go back to reference Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis. J R Soc Med. 1989;82:203–5.PubMed Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis. J R Soc Med. 1989;82:203–5.PubMed
9.
go back to reference Cohen AT, Alikhan R. Prophylaxis of venous thromboembolism in medical patients. Curr Opin Pulm Med. 2001;7:332–7.CrossRefPubMed Cohen AT, Alikhan R. Prophylaxis of venous thromboembolism in medical patients. Curr Opin Pulm Med. 2001;7:332–7.CrossRefPubMed
10.
go back to reference Samama MM, Cohen AT, Darmon J-Y, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients: prophylaxis in medical patients with Enoxaparin Study Group. N Engl J Med. 1999;341:793–800.CrossRefPubMed Samama MM, Cohen AT, Darmon J-Y, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients: prophylaxis in medical patients with Enoxaparin Study Group. N Engl J Med. 1999;341:793–800.CrossRefPubMed
11.
go back to reference Leizorovicz A, Cohen AT, Turpie AG, et al. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation. 2004;110:874–9.CrossRefPubMed Leizorovicz A, Cohen AT, Turpie AG, et al. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation. 2004;110:874–9.CrossRefPubMed
12.
go back to reference Cohen AT, Davidson BL, Gallus AS, et al. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomized placebo controlled trial. BMJ. 2006;332:325–9.CrossRefPubMed Cohen AT, Davidson BL, Gallus AS, et al. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomized placebo controlled trial. BMJ. 2006;332:325–9.CrossRefPubMed
13.
go back to reference Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(suppl):338S–400S.CrossRefPubMed Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(suppl):338S–400S.CrossRefPubMed
14.
go back to reference Nicolaides AN, Fareed J, Kakkar AK, et al. Prevention and treatment of venous thromboembolism International Consensus Statement (guidelines according to scientific evidence). Int Angiol. 2006;25:101–61. Nicolaides AN, Fareed J, Kakkar AK, et al. Prevention and treatment of venous thromboembolism International Consensus Statement (guidelines according to scientific evidence). Int Angiol. 2006;25:101–61.
15.
go back to reference Ageno W, Squizzato A, Ambrosini F, et al. Thrombosis prophylaxis in medical patients: a retrospective review of clinical practice patterns. Haematologica. 2002;87:746–50.PubMed Ageno W, Squizzato A, Ambrosini F, et al. Thrombosis prophylaxis in medical patients: a retrospective review of clinical practice patterns. Haematologica. 2002;87:746–50.PubMed
16.
go back to reference Ahmad HA, Geissler A, MacLellan DG. Deep venous thrombosis prophylaxis: are guidelines being followed? ANZ J Surg. 2002;72:331–4.CrossRefPubMed Ahmad HA, Geissler A, MacLellan DG. Deep venous thrombosis prophylaxis: are guidelines being followed? ANZ J Surg. 2002;72:331–4.CrossRefPubMed
17.
go back to reference Bergmann JF, Mouly S. Thromboprophylaxis in medical patients: focus on France. Semin Thromb Hemost. 2002;28(suppl):51–5.CrossRefPubMed Bergmann JF, Mouly S. Thromboprophylaxis in medical patients: focus on France. Semin Thromb Hemost. 2002;28(suppl):51–5.CrossRefPubMed
18.
go back to reference Goldhaber SZ, Tapson VF. DVT FREE Steering Committee; a prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol. 2004;93:259–62.CrossRefPubMed Goldhaber SZ, Tapson VF. DVT FREE Steering Committee; a prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol. 2004;93:259–62.CrossRefPubMed
19.
go back to reference Dobesh PP, Phillips KW, Haines ST. Improving the use of anticoagulant therapies in acutely ill medical patients. Am J Health Syst Pharm. 2008;65(15 Suppl 7):S5–12.CrossRefPubMed Dobesh PP, Phillips KW, Haines ST. Improving the use of anticoagulant therapies in acutely ill medical patients. Am J Health Syst Pharm. 2008;65(15 Suppl 7):S5–12.CrossRefPubMed
20.
go back to reference Sobieraj DM. Development and implementation of a program to assess medical patients’ need for venous thromboembolism prophylaxis. Am J Health Syst Pharm. 2008;65(18):1755–60.CrossRefPubMed Sobieraj DM. Development and implementation of a program to assess medical patients’ need for venous thromboembolism prophylaxis. Am J Health Syst Pharm. 2008;65(18):1755–60.CrossRefPubMed
21.
go back to reference Garcia DA, Highfill J, Finnerty K, Varoz E, McConkey S, Hutchinson K. Libby E: a prospective, controlled trial of a pharmacy-driven alert system to increase thromboprophylaxis rates in medical inpatients. Blood Coagul Fibrinolysis. 2009;20:541–5.CrossRefPubMed Garcia DA, Highfill J, Finnerty K, Varoz E, McConkey S, Hutchinson K. Libby E: a prospective, controlled trial of a pharmacy-driven alert system to increase thromboprophylaxis rates in medical inpatients. Blood Coagul Fibrinolysis. 2009;20:541–5.CrossRefPubMed
22.
go back to reference Rahima SA, Panjub A, Paib M, Ginsberg J. Venous thromboembolism prophylaxis in medical inpatients: a retrospective chart review. Thromb Res. 2003;111:215–9.CrossRef Rahima SA, Panjub A, Paib M, Ginsberg J. Venous thromboembolism prophylaxis in medical inpatients: a retrospective chart review. Thromb Res. 2003;111:215–9.CrossRef
23.
go back to reference Gubitz G, Counsell C, Sandercock P, Signorini D. Anticoagulants for acute ischaemic stroke (Cochrane Review). In: The Cochrane Library, vol. 2. Oxford: Update Software; 2003;87. Gubitz G, Counsell C, Sandercock P, Signorini D. Anticoagulants for acute ischaemic stroke (Cochrane Review). In: The Cochrane Library, vol. 2. Oxford: Update Software; 2003;87.
24.
go back to reference Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Forcier A, Patwardhan NA. Physician practices in the prevention of venous thromboembolism. Ann Intern Med. 1991;115:591–5.PubMed Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Forcier A, Patwardhan NA. Physician practices in the prevention of venous thromboembolism. Ann Intern Med. 1991;115:591–5.PubMed
25.
go back to reference Keane MG, Ingenito EP, Goldhaber SZ. Utilization of venous thromboembolism prophylaxis in the medical intensive care unit. Chest. 1994;106:13–4.CrossRefPubMed Keane MG, Ingenito EP, Goldhaber SZ. Utilization of venous thromboembolism prophylaxis in the medical intensive care unit. Chest. 1994;106:13–4.CrossRefPubMed
26.
go back to reference Fernandez BB Jr, Mink AM, Grove MK. Venous thromboembolism prophlylaxis, or lack of [Letter]. Chest. 1995;107:296.CrossRefPubMed Fernandez BB Jr, Mink AM, Grove MK. Venous thromboembolism prophlylaxis, or lack of [Letter]. Chest. 1995;107:296.CrossRefPubMed
27.
go back to reference Bauer JB, Chun DS, Karpinski TA. Pharmacist-led program to improve venous thromboembolism prophylaxis in a community hospital. Am J Health Syst Pharm. 2008;65(17):1643–7.CrossRefPubMed Bauer JB, Chun DS, Karpinski TA. Pharmacist-led program to improve venous thromboembolism prophylaxis in a community hospital. Am J Health Syst Pharm. 2008;65(17):1643–7.CrossRefPubMed
28.
go back to reference Ahonkhai AA, Gebo KA, Streiff MB, Moore RD, Segal JB. Venous thromboembolism in patients with HIV/AIDS a case-control study. J Acquir Immune Defic Syndr. 2008;48(3):310–4.CrossRefPubMed Ahonkhai AA, Gebo KA, Streiff MB, Moore RD, Segal JB. Venous thromboembolism in patients with HIV/AIDS a case-control study. J Acquir Immune Defic Syndr. 2008;48(3):310–4.CrossRefPubMed
29.
go back to reference Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med. 1991;151(5):933–8.CrossRefPubMed Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med. 1991;151(5):933–8.CrossRefPubMed
30.
go back to reference Robert-Ebadi H, Le Gal G, Righini M. Use of anticoagulants in elderly patients: practical recommendations. Clin Interv Aging. 2009;4:165–77.PubMed Robert-Ebadi H, Le Gal G, Righini M. Use of anticoagulants in elderly patients: practical recommendations. Clin Interv Aging. 2009;4:165–77.PubMed
31.
go back to reference Mant M, Geerts B. Clinical guide—DVT prophylaxis in major orthopedic surgery. The thrombosis interest group of Canada (Sep 2006). Mant M, Geerts B. Clinical guide—DVT prophylaxis in major orthopedic surgery. The thrombosis interest group of Canada (Sep 2006).
32.
go back to reference Tapson VF. The role of smoking in coagulation and thromboembolism in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2:71–7.CrossRefPubMed Tapson VF. The role of smoking in coagulation and thromboembolism in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2:71–7.CrossRefPubMed
Metadata
Title
Is deep vein thrombosis prophylaxis appropriate in the medical wards? A clinical pharmacists’ intervention study
Authors
Hossein Khalili
Simin Dashti-Khavidaki
Azita Hajhossein Talasaz
Laleh Mahmoudi
Kaveh Eslami
Hamed Tabeefar
Publication date
01-10-2010
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 5/2010
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-010-9412-y

Other articles of this Issue 5/2010

International Journal of Clinical Pharmacy 5/2010 Go to the issue